skip to main content
European Commission Logo
en English
Newsroom

Overview    News

Medical devices: European Commission asks for further scientific study and draws first lessons from the recent fraud on breast implants

Following the publication of the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) on the safety of silicone products manufactured by the Poly Implant Prothèse (PIP) Company, the European Commission requested to conduct further in-depth study on the potential health impact of faulty breast implants.

Related topics

Medical devices

date:  28/01/2015

The Commission will also discuss with the Member States how surveillance of the medical devices can already be reinforced immediately within the existing legislative framework. In parallel a "stress test" of the legislation on medical devices is under way in order to identify how best the questions raised by this issue can be addressed in the revision of this framework already foreseen for 2012.

Press release